Select Publications
Conference Abstracts
2019, 'Method development and proteomic analysis of depleted plasma for biomarker discovery in neurodegenerative diseases [Poster Abstract P2-219].S', in Alzheimer's & Dementia, Elsevier BV, Los Angeles, CA, USA, Vol. 15, pp. P661 - P661, presented at Alzheimer's Association International Conference (AAIC) 2019, Los Angeles, CA, USA, 14 July 2019 - 16 July 2019, http://dx.doi.org/10.1016/j.jalz.2019.06.2626
,2018, 'CSF and blood biomarkers of early-onset Alzheimer’s disease: a systematic review and meta-analysis [Poster Abstract P3-226]', in Alzheimer's & Dementia, Elsevier BV, Chicago, USA, Vol. 14, pp. P1158 - P1158, presented at Alzheimer’s Association International Conference (AAIC) 2018, Chicago, USA, 22 July 2018 - 26 July 2018, http://dx.doi.org/10.1016/j.jalz.2018.06.1585
,2017, 'Identification of Cerebral Metal Ion Imbalance in the Brain of Ageing Octodon Degu: a Natural Model for Alzheimer's Disease [Poster Abstract P2-080]', in Alzheimer's and Dementia, Elsevier, London, UK, Vol. 13, pp. P636 - P637, presented at Alzheimer's Association International Conference (AAIC) 2017, London, UK, 16 July 2017 - 20 July 2017, http://dx.doi.org/10.1016/j.jalz.2017.06.729
,2017, 'Proteomics of the Alzheimer's disease brain: Neuropathology and neuroresilience [Poster Abstract P2-155]', in Alzheimer's and Dementia, Elsevier, London, UK, Vol. 13, pp. P667 - P667, presented at Alzheimer's Association International Conference (AAIC) 2017, London, UK, 16 July 2017 - 20 July 2017, http://dx.doi.org/10.1016/j.jalz.2017.06.806
,2017, 'Sirtuin protein and related energy metabolite changes in the Alzheimer brain [Poster Abstract P2-182]', in Alzheimer's and Dementia, Elsevier, London, UK, Vol. 13, pp. P676 - P676, presented at lzheimer's Association International Conference (AAIC) 2017, London, UK, 16 July 2017 - 20 July 2017, http://dx.doi.org/10.1016/j.jalz.2017.06.833
,2016, 'Plasma apolipoproteins and physical and cognitive health in very old individuals.', in Alzheimer's & dementia : translational research & clinical interventions, Wiley, Toronto, Canada, Vol. 12, pp. P868 - P868, presented at Alzheimer's Association International Conference (AAIC) 2016, Toronto, Canada, 24 July 2016 - 28 July 2016, http://dx.doi.org/10.1016/j.jalz.2016.06.1786
,2014, 'A genome-wide meta-analysis of plasma clusterin levels in the CHARGE consortium [Abstract P3-071]', in Alzheimer's & Dementia, Copenhagen, Denmark, Vol. 10, pp. P652 - P653, presented at Alzheimer’s Association International Conference (AAIC) 2014, Copenhagen, Denmark, 12 July 2014 - 17 July 2014, http://dx.doi.org/10.1016/j.jalz.2014.05.1159
,2014, 'Genome-wide significant results identified for plasma apolipoprotein H levels [Abstract P4-012]', in Alzheimer's & Dementia, Copenhagen, Denmark, Vol. 10, pp. P788 - P788, presented at Alzheimer's Association International Conference (AAIC) 2014, Copenhagen, Denmark, 12 July 2014 - 17 July 2014, http://dx.doi.org/10.1016/j.jalz.2014.05.1526
,2013, 'Development of a targeted mass spectrometry method for accurate quantification of human sirtuins in biological samples [Abstract P2-035]', in Alzheimer's & Dementia, Boston, MA, USA, Vol. 9, pp. P357 - P357, presented at Alzheimer’s Association International Conference (AAIC) 2013, Boston, MA, USA, 13 July 2013 - 18 July 2013, http://dx.doi.org/10.1016/j.jalz.2013.05.677
,2013, 'Plasma beta-amyloid correlates with cognition and brain volumetrics in mild cognitive impairment [Abstract P1-242]', in Alzheimer's & Dementia, Boston, MA, USA, Vol. 9, pp. P241 - P241, presented at Alzheimer’s Association International Conference (AAIC) 2013, Boston, MA, USA, 13 July 2013 - 18 July 2013, http://dx.doi.org/10.1016/j.jalz.2013.05.466
,2013, 'Plasma protein profiling of mild cognitive impairment and Alzheimer's disease [Abstract P1-241]', in Alzheimer's & Dementia, Boston, MA, USA, Vol. 9, pp. P240 - P241, presented at Alzheimer’s Association International Conference (AAIC) 2013, Boston, MA, USA, 13 July 2013 - 18 July 2013, http://dx.doi.org/10.1016/j.jalz.2013.05.465
,2013, 'γ-glutamylcysteine (GGC)-mediated upregulation of glutathione levels can ameliorate toxicity of natural beta-amyloid oligomers in primary adult human neurons [Abstract P4-332]', in Alzheimer's & Dementia, Boston, MA, USA, Vol. 9, pp. P854 - P854, presented at Alzheimer’s Association International Conference (AAIC) 2013, Boston, MA, USA, 13 July 2013 - 18 July 2013, http://dx.doi.org/10.1016/j.jalz.2013.08.166
,2012, 'NAD+ metabolism, and oxidative stress in the brain of aging Wistar rats: Is there a link? [Abstract P3-073]', in Alzheimer's & Dementia, Vancouver, Canada, Vol. 8, pp. P478 - P478, presented at Alzheimer’s Association International Conference (AAIC) 2012, Vancouver, Canada, 14 July 2012 - 19 July 2012, http://dx.doi.org/10.1016/j.jalz.2012.05.1292
,2012, 'Sirtuin expression during aging and in Alzheimer's disease [Abstract P2-094]', in Alzheimer's & Dementia, Vancouver, Canada, Vol. 8, pp. P295 - P296, presented at Alzheimer’s Association International Conference (AAIC) 2012, Vancouver, Canada, 14 July 2012 - 19 July 2012, http://dx.doi.org/10.1016/j.jalz.2012.05.798
,(ed.), 2011, 'Plasma apolipoproteins as biomarkers of mild cognitive impairment in a community-based sample [Abstract P1-115]', in Alzheimer's and Dementia, Elsevier, Orlando, Florida, Vol. 7, pp. S146 - S146, presented at Alzheimer’s Association International Conference on Alzheimer's Disease, Paris, France, 16 July 2011 - 21 July 2011
,2011, 'Screening and validation of plasma biomarkers for mild cognitive impairment and Alzheimer's disease [Abstract ORAL-06-02]', in Proceedings of the 31st ANS Annual Meeting, online, pp. 39 - 39, presented at Australian Neuroscience Society 31st Annual Meeting, Auckland, New Zealand, 31 January 2011 - 03 February 2011
,2010, 'Meta-analysis of plasma amyloid beta levels using cross-sectional and longitudinal studies of Alzheimer's disease and dementia [Abstract P3-249]', in Alzheimer's & Dementia, Honolulu, Hawaii, USA, Vol. 6, pp. S524 - S524, presented at Alzheimer’s Association International Conference (AAIC) 2010, Honolulu, Hawaii, USA, 10 July 2010 - 15 July 2010, http://dx.doi.org/10.1016/j.jalz.2010.05.1748
,2010, 'Screening plasma for biomarkers of mild cognitive impairment and Alzheimer's disease by quantitative proteomic methods [Abstract O3-03-03]', in Alzheimer's & Dementia, Honolulu, Hawaii, USA, Vol. 6, pp. S129 - S130, presented at Alzheimer’s Association International Conference (AAIC) 2010, Honolulu, Hawaii, USA, 10 July 2010 - 15 July 2010, http://dx.doi.org/10.1016/j.jalz.2010.05.406
,2009, 'Diagnostic biomarkers of mild cognitive impairment and Alzheimer's disease: A plasma proteomics approach [Oral Abstract]', in Australasian Journal of Ageing, Canberra, Vol. 28, pp. A71 - A72, presented at 42nd National Conference of the Australian Association of Gerontology, Canberra, 25 November 2009 - 27 November 2009, http://dx.doi.org/10.1111/j.1741-6612.2009.00397.x
,2009, 'o,o’-Dityrosine (DT) as an index of free radical activity in ageing and inflammatory diseases [Abstract No. 395]', in Proceedings of the 7th ASMS Conference on Mass Spectrometry, Philadelphia, Pennsylvania, USA, presented at 7th ASMS Conference on Mass Spectrometry, Philadelphia, Pennsylvania, USA, 31 May 2009 - 04 June 2009
,2008, 'Plasma levels of Aβ1-40 and Aβ1-42 peptides in Patients with mild cognitive impairment, Alzheimer's disease and stroke [Abstract P1-204]', in Alzheimer's & Dementia, Chicago, Illinois, USA, Vol. 4, pp. T269 - T269, presented at Alzheimers Association International Conference (AAIC) 2008, Chicago, Illinois, USA, 26 July 2008 - 31 July 2008, http://dx.doi.org/10.1016/j.jalz.2008.05.793
,2006, 'Correlation of plasma levels of Aβ 1-40 and Aβ 1-42 peptides in patients with mild cognitive impairment, Alzheimer’s disease and stroke [Abstract Poster PO76]', in Neuropsychiatric Disease and Treatment, Dove Medical Press, Cheshire, UK, Vol. 2, pp. S148 - S148, presented at 6th International Neuropsychiatric Association Congress, Sydney, 10 September 2006 - 14 September 2006
,2006, 'Quantification of O- and M-tyrosine levels in Alzheimer’s plasma proteins [Abstract Poster PO077]', in Neuropsychiatric Disease and Treatment, Dove Medical Press, Cheshire, UK, Vol. 2, pp. S148 - S148, presented at 6th International Neuropsychiatric Association Congress, Sydney, 10 September 2006 - 14 September 2006
,2005, 'Reduced nicotinamide but unchanged quinolinic acid concentrations in Alzheimer brain cortical regions [Abstract]', in Proceedings of the Tryptophan Metabolism National Meeting 2005, Athol Lykke Theatre, School of Medical Sciences, University of New South Wales, Sydney, Australia, presented at Tryptophan Metabolism National Meeting 2005, Athol Lykke Theatre, School of Medical Sciences, University of New South Wales, Sydney, Australia, 09 December 2005
,Preprints
2024, Identifying regulators of associative learning using a protein-labelling approach inC. elegans, http://dx.doi.org/10.1101/2024.02.19.580416
,2022, Oocyte and cumulus cell cooperativity and metabolic plasticity under the direction of oocyte paracrine factors, http://dx.doi.org/10.1101/2022.09.05.506599
,2022, Deep proteome analysis of plasma reveals novel biomarkers of mild cognitive impairment and Alzheimer’s disease: A longitudinal study, http://dx.doi.org/10.1101/2022.01.30.478370
,2022, Impact of APOE ε3 and ε4 genotypes on plasma proteome signatures in Alzheimer's disease, http://dx.doi.org/10.21203/rs.3.rs-1535069/v1
,2022, Impact of APOE ε3 and ε4 genotypes on plasma proteome signatures in Alzheimer’s disease, http://dx.doi.org/10.1101/2022.01.29.478291
,2021, Differential mitochondrial protein interaction profile between human translocator protein and its A147T polymorphism variant, http://dx.doi.org/10.1101/2021.07.23.453531
,